Evidence map›Paper›PMID 34109383›Full record

ArticleRadiation protection dosimetry2021

ON THE POSSIBILITY TO RESOLVE GADOLINIUM- AND CERIUM-BASED CONTRAST AGENTS FROM THEIR CT NUMBERS IN DUAL-ENERGY COMPUTED TOMOGRAPHY.

Alexandr Malusek, Lilian Henriksson, Peter Eriksson, Nils Dahlström, Åsa Carlsson Tedgren, Kajsa Uvdal

Open access · hybridAbstract read
In one paragraph

Article in Radiation protection dosimetry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alexandr MalusekDepartment of Health, Medicine and Caring Sciences, Linköping University, SE-581 83, Linköping, Sweden.
Lilian HenrikssonCenter for Medical Image Science and Visualization (CMIV), Linköping University, SE-581 83, Linköping, Sweden.
Peter ErikssonDepartment of Physics, Chemistry and Biology, Linköping University, SE-581 83, Linköping, Sweden.
Nils DahlströmDepartment of Health, Medicine and Caring Sciences, Linköping University, SE-581 83, Linköping, Sweden.
Åsa Carlsson TedgrenDepartment of Health, Medicine and Caring Sciences, Linköping University, SE-581 83, Linköping, Sweden.
Kajsa UvdalDepartment of Physics, Chemistry and Biology, Linköping University, SE-581 83, Linköping, Sweden.
Linköping University · SEKarolinska University Hospital · SE

Funding

Swedish Research Council VR-NT 2016-05033
6 · The paper itself

Abstract

Cerium oxide nanoparticles with integrated gadolinium have been proved to be useful as contrast agents in magnetic resonance imaging. Of question is their performance in dual-energy computed tomography. The aims of this work are to determine (1) the relation between the computed tomography number and the concentration of the I, Gd or Ce contrast agent and (2) under what conditions it is possible to resolve the type of contrast agent. Hounsfield values of iodoacetic acid, gadolinium acetate and cerium acetate dissolved in water at molar concentrations of 10, 50 and 100 mM were measured in a water phantom using the Siemens SOMATOM Definition Force scanner; gadolinium- and cerium acetate were used as substitutes for the gadolinium-integrated cerium oxide nanoparticles. The relation between the molar concentration of the I, Gd or Ce contrast agent and the Hounsfield value was linear. Concentrations had to be sufficiently high to resolve the contrast agents.

Indexed as

CeriumContrast MediaGadoliniumMagnetic Resonance ImagingPhantoms, ImagingTomography, X-Ray ComputedCeriumContrast MediaGadolinium

Identifiers

PMID34109383
PMCPMC8507471
OpenAlexW3166953390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.